The Board of Pharmacy published the following effective May 12, 2021:
- Final rule amends and adopts regulations under 657 IAC 3 and 6 related to pharmacy technicians and general pharmacy practice including broader language relating to the delegation of nonclinical pharmacy functions to a pharmacy technician beyond those related solely to dispensing; prohibiting a pharmacy license holder from requiring a supervising pharmacist to delegate functions to a technician against the pharmacist’s professional judgment; changes related to pharmacy technician registration and the renewal period for certified pharmacy technicians; and other related amendments outlined in the posting;
- Final rule amends and adopts regulations under 657 IAC 5 to require registration of pharmacy support persons before employment in a pharmacy. The rule also aligns the late renewal and reactivation procedures for those with other licenses and registrations, adds a $15 fee for written verification of registration, and expands the delegation of nontechnical pharmacy functions to pharmacy support persons. Additionally, the rule prohibits requiring a supervising pharmacist to delegate functions to a support person against their professional judgment, requires support persons to report any criminal conviction or disciplinary action within 30 days, and adds provisions on the online application process.
- Final rule amends regulations under 657 IAC 4 to require pharmacist-interns to notify the board of changes in name, address, email, any criminal convictions, or disciplinary action. The rule also requires the submission of a $15 fee for verification of a pharmacist-intern registration or certification of hours and removes the reference to a license surcharge for the Board’s monitoring program.
- Final rule amends regulations under 657 IAC 37 to require reporting of Schedule V controlled substances to the prescription monitoring program database. The rule also revises the definition of “health care professional.”
- Final rule amends regulations under 657 IAC 10 to temporarily add oliceridine and remimazolam as controlled substances to conform to federal standards.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.